European Archives of Oto-Rhino-Laryngology

, Volume 264, Issue 8, pp 887–893 | Cite as

The role of interleukin-16 in eosinophilic chronic rhinosinusitis

  • Andreas Lackner
  • Reinhard Bernd Raggam
  • Heinz Stammberger
  • Alfred Beham
  • Hannes Braun
  • Barbara Kleinhappl
  • Walter Buzina
  • Clemens Kittinger
  • Sabine Reinisch
  • Andrea Berghold
  • Kurt Freudenschuss
  • Sonja Barth
  • Egon Marth
Rhinology

Abstract

Eosinophilic granulocytes (Eos) are found in great numbers both in the tissue and in the mucus of patients suffering from chronic rhinosinusitis with polyposis (ECRS). Interleukin-16 (IL-16) is known as a highly potent chemotactic and chemoattractant molecule (ED 10−11) for Eos. In an open, explorative, controlled study we examined the presence of IL-16 in mucosa tissue, mucus and serum in patients suffering from ECRS and its association to Eos activation. Tissue and nasal mucus specimen from 10 previously untreated, non allergic ECRS-patients undergoing paranasal sinus surgery and from 10 healthy non sinusitis subjects, undergoing nasal surgery because of anatomic nasal obstruction were investigated by real-time (RT-) PCR targeting human IL-16 mRNA. Haematoxylin-eosin (HE) staining and immunohistochemistry of formalin embedded tissue and mucus were applied for detection and determination of the proportion of activated Eos (aEos) and IL-16. Serum IL-16 was analyzed by enzyme-linked-immunosorbent assay (ELISA). IL-16 mRNA and IL-16 protein levels were elevated in nasal mucus, polyp tissue and in the serum of ECRS patients compared to healthy controls. There was a high proportion of aEos in ECRS patients compared to healthy subjects. Serum IL-16, IL-16 mRNA expression and IL-16 protein in mucus and tissue specimens were significantly associated with the presence of aEos in polyps of ECRS patients. Immunohistochemically IL-16 protein was mainly expressed in aEos, mast cells, lymphocytes and epithelial cells. In conclusion our data indicate that IL-16 may stimulate the migration and persistence of activated Eos in ECRS. IL-16 production in ECRS patients is not mediated by Immunglobuline-E (IgE).

Keywords

Chronic rhinosinusitis Eosinophils IL-16 

References

  1. 1.
    Bachert C, Gevaert P, Holtappels G, Cuvelier C, Van Cauwenberge P (2000) Nasal polyposis: from cytokines to growth. Am J Rhinol 14:279–290PubMedGoogle Scholar
  2. 2.
    Bandeira-Melo C, Sugiyama K, Woods LJ, et al (2002) IL-16 Promotes leukotriene C4 and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J Immunol 168:4756–4763PubMedGoogle Scholar
  3. 3.
    Benninger MS, Ferguson BJ, Hadley JA, et al (2003) Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 129S:1–32CrossRefGoogle Scholar
  4. 4.
    Blaschke V, Reich K, Blaschke S, Zipprich S, Neumann C (2000) Rapid quantitation of proinflammatory and chemoattractant cytokine expression in small tissue samples and monocyte-derived dendritic cells: validation of a new real-time RT-PCR technology. J Immunol Methods 246:79–90PubMedCrossRefGoogle Scholar
  5. 5.
    Cheng G, Ueda T, Eda F, Arima M, Yoshida N, Fukuda T (2001) A549 Cells can express interleukin-16 and stimulate eosinophil chemotaxis. Am J Respir Cell Mol Biol 25:212–218PubMedGoogle Scholar
  6. 6.
    Cruikshank WW, Kornfeld H, Center DM (2000) Interleukin-16. J Leukoc Biol 67:757–766PubMedGoogle Scholar
  7. 7.
    Ferland C, Flamand N, Davoine F, Chakir J, Laviolette M (2004) IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signalling and by modulating CD4 eosinophil expression. J Immunol 173:4417–4424PubMedGoogle Scholar
  8. 8.
    Hamilos DL, Leung DYM, Wood R, et al (1995) Evidence for distinct cytokine expression in allergic versus non aöllergic chronic sinusitis. J Allergy Clin Immunol 96:537–544PubMedCrossRefGoogle Scholar
  9. 9.
    Karaki M, Dobashi H, Kobayashi R, Tokuda M, Ishida T, Mori N (2005) Expression of interleukin-16 in allergic rhinitis. Int Arch Allergy Immunol 238:67–72CrossRefGoogle Scholar
  10. 10.
    Katzenstein AL, Sale SR, Greenberger PA (1983) Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 72:89–93PubMedCrossRefGoogle Scholar
  11. 11.
    Kountakis SE, Arango P, Bradley D, Wade ZK, Borish L (2004) Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope 114:1895–1905PubMedCrossRefGoogle Scholar
  12. 12.
    Laberge S, Durham SR, Ghaffer O, et al (1997) Expression of IL-16 in allergen-induced late-phase nasal responses and relation to topical glucocorticosteroid treatment. J Allergy Clin Immunol 100:569–574PubMedCrossRefGoogle Scholar
  13. 13.
    Laberge S, Pinsonneault S, Varga EM, et al (2000) Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma. J Allergy Clin Immunol 106:293–301PubMedCrossRefGoogle Scholar
  14. 14.
    Lee CH, Lee KS, Rhee CO, Lee SO, Min YG (1999) Distribution of RANTES and IL-5 in allergic nasal mucosa and nasal polyps. Ann Otol Rhinol Laryngol 108:594–598PubMedGoogle Scholar
  15. 15.
    Meltzer EO, Hamilos DL, Hadley JA, et al (2004) Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol Suppl 114(6):155–211CrossRefGoogle Scholar
  16. 16.
    Pullerits T, Lindén A, Malmhäll C, Lötvall J (2001) Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy 56:871–877PubMedCrossRefGoogle Scholar
  17. 17.
    Stordeur P, Poulin LF, Craciun L, Zhou L, Schandené L, Lavareille de A, Goriely S, Goldman M (2002) Cytokine mRNA quantification by real-time PCR. J Immunol Methods 259:55–64PubMedCrossRefGoogle Scholar
  18. 18.
    Steiner E, Kleinhappl B, Gutschi A, Marth E (1998) Analysis of hsp 70 mRNA levels in HepG2 cells exposed to various metals differing in toxicity. Toxicol Lett 97:169–176CrossRefGoogle Scholar
  19. 19.
    Taha RA, Laverge S, Hamid Q, Olivenstein R (2001) Increased expression of the chemo attractant cytokinese, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120:595–601PubMedCrossRefGoogle Scholar
  20. 20.
    Takeno S, Hirakawa K, Ueda T, Furukida K, Osada R, Yajin K (2002) Nuclear faktor-kappa B activation in the nasal polyp epithelium: relationship to local cytokine gene expression. Laryngoscope 112:53–58PubMedCrossRefGoogle Scholar
  21. 21.
    Yang M, Hogan SP, Mahalingam S, et al (2003) Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 112:935–943PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Andreas Lackner
    • 1
  • Reinhard Bernd Raggam
    • 2
  • Heinz Stammberger
    • 1
  • Alfred Beham
    • 3
  • Hannes Braun
    • 1
  • Barbara Kleinhappl
    • 2
  • Walter Buzina
    • 2
  • Clemens Kittinger
    • 2
  • Sabine Reinisch
    • 1
  • Andrea Berghold
    • 4
  • Kurt Freudenschuss
    • 1
  • Sonja Barth
    • 2
  • Egon Marth
    • 2
  1. 1.Department of Otorhinolaryngology, Head and Neck SurgeryMedical University GrazGrazAustria
  2. 2.Institute of HygieneMedical University GrazGrazAustria
  3. 3.Institute for PathologyMedical University GrazGrazAustria
  4. 4.Institute for Medical Informatics, Statistics and DocumentationMedical University GrazGrazAustria

Personalised recommendations